Tickertape - Financial freedom begins here

Thirumalai Chemicals has allotted 18,96,614 equity shares of face value of Re 1 at a price of Rs 296/- (including a premium of Rs 295/- each) per equity share aggregating to Rs 56,13,97,744/- on preferential basis to the Promoter(s) and Person(s) belonging to Promoter Group. Powered by Capital Market - Live

 Spandana Sphoorty Financial has allotted 41,500 Listed, Senior, Secured, Redeemable, Taxable, Non-Convertible Debentures having face value of Rs 1,00,000/- per debenture, aggregating Rs 415 crore on private placement basis.Powered by Capital Market - Live

ICICI Prudential Life Insurance Company has allotted 161,107 equity shares under ESOP on 23 December 2025. Powered by Capital Market - Live

ICICI Lombard General Insurance Company has allotted 40,020 equity shares under ESOS on 22 December 2025. Powered by Capital Market - Live

Bioeq AG (Bioeq), a Swiss biopharmaceutical company, and Zydus Lifesciences (Zydus), an innovation-led life-sciences company with an international presence, today announced that its wholly owned subsidiary, Zydus Lifesciences Global FZE, United Arab Emirates has entered into a strategic partnership with Bioeq, for the licensing, supply and commercialization of Bioeq`s Vascular Endothelial Growth Factor (VEGF) inhibitor NUFYMCO', an interchangeable biosimilar of Lucentis' (Ranibizumab) for the U.S. market. The Biologics License Application (BLA) for NUFYMCO' has been approved by U.S. Food and Drug Administration (USFDA) on December 18, 2025. This transaction marks an expansion of Zydus' U.S. biosimilar business, following its recent partnership with Formycon AG for a biosimilar of Keytruda' (Pembrolizumab). Under the terms of this agreement, Bioeq will be responsible for the development, manufacturing, registration and supply of the finished product, while Zydus will be responsible for the commercialisation of NUFYMCO' in the U.S. market.  Powered by Capital Market - Live

Dalmia Bharat has allotted 792 equity shares under ESOP on 23 December 2025. Consequent to the aforesaid allotment, the issued & paid-up share capital of the Company stands increased from Rs. 37,51,30,322/- comprising 18,75,65,161 equity shares of Rs. 2/- each, to Rs. 37,51,31,906/- comprising 18,75,65,953 equity shares of Rs. 2/- each.Powered by Capital Market - Live

Solar Industries India has issued commercial paper aggregating to an amount of Rs 100 crore on 23 December 2025. Powered by Capital Market - Live

Axis Bank has allotted 5,02,455 equity shares of Rs. 2/- each of the Bank on December 23, 2025, pursuant to exercise of stock options / units under its ESOP / RSU Scheme. The paid-up share capital of the Bank has accordingly increased from Rs. 6,208,977,028 (3,104,488,514 equity shares of Rs. 2/- each) to Rs. 6,209,981,938 (3,104,990,969 equity shares of Rs. 2/- each). Powered by Capital Market - Live

CG Power & Industrial Solutions has allotted 5,000 equity shares under ESOP on 23 December 2025. Consequently, on allotment of the above equity shares, the paid-up equity share capital of the Company stands increased from Rs. 3,14,97,15,218 to Rs. 3,14,97,25,218 comprising of 1,57,48,62,609 equity shares of face value of Rs. 2/- each. Powered by Capital Market - Live

The Government of Chhattisgarh and GAIL (India) today joined hands for development of a greenfield gas-based fertilizer project in the State of Chhattisgarh. As per the MoU, GAIL will undertake detailed techno-economic studies for setting up a urea manufacturing plant of 12.7 Lacs Metric Ton (LMT), proposed to be strategically located along GAIL's Mumbai-Nagpur-Jharsuguda Natural Gas Pipeline (MNJPL) corridor. Based on the techno-economic evaluation, investment decision will be taken for setting up the fertilizer project by GAIL. The Government of Chhattisgarh will provide facilitation across all stages of the project, including support for feasibility studies, identification and allocation of suitable land parcels, coordination with State and Central authorities, facilitation for statutory approvals and enabling infrastructure necessary for project implementation. Powered by Capital Market - Live